YPSN Ypsomed Holding AG

SWX · CH · Healthcare · Medical Instruments & Supplies · ypsomed.com

357.80CHF-0.83%Mkt Cap: 5.37B $P/E: 21.953d ago

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

$49.21BUSDP/E 42.0

MDLN

Medline Inc. - Class A common stock

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc. - Common Stock

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

Key Statistics

Company

Market Cap5.37B USD

Enterprise Value5.68B USD

Revenue (TTM)834.27M USD

Gross Profit359.06M USD

Net Income (TTM)253.29M USD

Revenue/Share53.72 CHF

Last Price357.80 CHF

Fiscal Year EndMar 2026

MR QuarterMar 2026

Employees2.0K

CountryCH

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINCH0019396990

Valuation

P/E (Trailing)21.95

P/E (Forward)24.51

PEG3.28

EV/EBITDA15.27

EV/Revenue6.81

P/S6.49

P/B6.34

EPS (TTM)16.30

EPS (Forward)14.72

52W Range

260.5062% of range418.00

52W High418.00 CHF

52W Low260.50 CHF

Profitability

Gross Margin43.04%

Oper. Margin26.45%

EBITDA Margin44.57%

Profit Margin30.36%

ROE29.66%

ROA16.48%

Growth

Revenue Growth-13.30%

Earnings Growth51.70%

Cash Flow & Leverage

Operating CF350.11M USD

CapEx (TTM)368.76M USD

FCF Margin-7.83%

FCF Yield-1.22%

Net Debt265.02M USD

Net Debt/EBITDA0.71

Balance Sheet

Debt/Equity0.35

Current Ratio1.07

Quick Ratio0.73

Book Value/Sh56.91 CHF

Cash/Share2.17 CHF

Dividends

Fwd Div Rate4.40 CHF

Trail. Div Rate4.40 CHF

Div. Yield1.20%

5Y Avg Yield0.56%

Payout Ratio13.50%

Ex-Div DateJul 3, 2026

Pay DateJul 3, 2024

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)397.00 CHF

Upside (mean)+11.0%

Target Range280.00 CHF – 480.00 CHF

280.00+11.0% to mean480.00

# Analysts13

Ownership

Shares Out.13.15M

Float3.51M

Insiders69.59%

Institutions15.31%

Technical

SMA 50386.20 (-7.4%)

SMA 200333.60 (+7.3%)

Beta0.77

S&P 52W Chg13.94%

Avg Vol (30d)16.96K

Avg Vol (10d)19.56K

Technical Indicators

RSI (14)40.1

MACD-6.8339

MACD Signal-7.9305

MACD Hist.+1.0966

BB Upper389.60 CHF

BB Middle363.08 CHF

BB Lower336.56 CHF

BB Width14.61%

ATR (14)9.209 CHF

Vol Ratio (20d)0.40x